Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS)

  • Chapter
  • First Online:
Extreme Hepatic Surgery and Other Strategies

  • 1382 Accesses

Abstract

The possibility to achieve a curative resection in patients with colorectal liver metastases (CLM) is limited by the future liver remnant (FLR), posthepatectomy liver failure (PHLF) being the most severe complication after major liver resections. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) has recently been introduced as a promising two-stage strategy to induce large FLR hypertrophy within a brief time interval. The technique consists in right portal vein ligation combined with in-situ splitting of liver parenchyma during the first stage, followed 7–10 days after by a second stage resecting the diseased hemi-liver. This short-interval two-stage strategy has been demonstrated to provide high resectability rates in patients with otherwise unresectable CLM, where almost all patients eventually benefit from a curative resection. Despite the relatively high morbidity and mortality rates reported in most series during the learning curve, recent evidence indicates that ALPPS can be performed with acceptable morbidity and mortality in experienced centers, comparable to conventional two-stage hepatectomies. In terms of oncological outcomes, the short-term results available are similar to that of conventional approaches. Therefore, it seems that ALPPS will never replace PVE for patients with a tumor-free FLR, but it might become a good option in certain cases with bilateral disease if future evidence demonstrates better or equal long-term outcomes compared with classical two-stage liver resections. Given that ALPPS is a challenging surgical innovation under development, it should be performed only at high-volume specialized centers, on patients selected by a multidisciplinary team, and included in the International ALPPS Registry.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006;13(10):1271–80.

    Article  PubMed  Google Scholar 

  2. Tzeng CW, Aloia TA. Colorectal liver metastases. J Gastrointest Surg. 2013;17(1):195–201.

    Article  PubMed  Google Scholar 

  3. Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN, et al. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013;15(2):91–103.

    Article  PubMed Central  Google Scholar 

  4. Vauthey JN, Pawlik TM, Abdalla EK, Arens JF, Nemr RA, Wei SH, et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg. 2004;239(5):722–30.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713–24.

    Article  PubMed  Google Scholar 

  6. Mise Y, Sakamoto Y, Ishizawa T, Kaneko J, Aoki T, Hasegawa K, et al. A worldwide survey of the current daily practice in liver surgery. Liver Cancer. 2013;2(1):55–66.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Liu H, Zhu S. Present status and future perspectives of preoperative portal vein embolization. Am J Surg. 2009;197(5):686–90.

    Article  PubMed  Google Scholar 

  8. Wicherts DA, Miller R, de Haas RJ, Bitsakou G, Vibert E, Veilhan LA, et al. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg. 2008;248(6):994–1005.

    Article  PubMed  Google Scholar 

  9. Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011;29(8):1083–90.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232(6):777–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling two-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255(3):405–14.

    Article  PubMed  Google Scholar 

  12. de Santibañes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the “ALPPS” approach. Ann Surg. 2012;255(3):415–7.

    Article  PubMed  Google Scholar 

  13. Worldwide registry of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Data management system. www.alpps.net.

  14. Oldhafer KJ, Stavrou GA, van Gulik TM, Core Group. ALPPS—where do we stand, where do we go?: eight recommendations from the first international expert meeting. Ann Surg. 2016;263(5):839–41.

    Article  PubMed  Google Scholar 

  15. Alvarez FA, Ardiles V, de Santibañes M, Pekolj J, de Santibañes E. Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center. Ann Surg. 2015;261(4):723–32.

    Article  PubMed  Google Scholar 

  16. Hernandez-Alejandro R, Bertens KA, Pineda-Solis K, Croome KP. Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases? Surgery. 2015;157(2):194–201.

    Article  PubMed  Google Scholar 

  17. Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-Alejandro R, et al. Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg. 2014;260(5):829–36.

    Article  PubMed  Google Scholar 

  18. Sahani DV, Bajwa MA, Andrabi Y, Bajpai S, Cusack JC. Current status of imaging and emerging techniques to evaluate liver metastases from colorectal carcinoma. Ann Surg. 2014;259(5):861–72.

    Article  PubMed  Google Scholar 

  19. Ferrero A, Viganò L, Polastri R, Muratore A, Eminefendic H, Regge D, et al. Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg. 2007;31(8):1643–51.

    Article  PubMed  Google Scholar 

  20. Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, Loyer EM, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl. 2002;8(3):233–40.

    Article  PubMed  Google Scholar 

  21. Linecker M, Stavrou GA, Oldhafer KJ, et al. The ALPPS risk score: avoiding futile use of ALPPS. Ann Surg. 2016;264(5):763–71.

    Article  PubMed  Google Scholar 

  22. Alvarez FA, Ardiles V, Sanchez Claria R, Pekolj J, de Santibañes E. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks. J Gastrointest Surg. 2013;17:814–21.

    Article  PubMed  Google Scholar 

  23. Petrowsky H, Györi G, de Oliveira M, Lesurtel M, Clavien PA. Is partial-ALPPS safer than ALPPS? A single-center experience. Ann Surg. 2015;261(4):e90–2.

    Article  PubMed  Google Scholar 

  24. Nadalin S, Capobianco I, Li J, Girotti P, Königsrainer I, Königsrainer A. Indications and limits for associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Lessons learned from 15 cases at a single centre. Z Gastroenterol. 2014;52(1):35–42.

    Article  CAS  PubMed  Google Scholar 

  25. Dokmak S, Belghiti J. Which limits to the “ALPPS” approach? Ann Surg. 2012;256(3):e6; author reply e16–7.

    Google Scholar 

  26. Gauzolino R, Castagnet M, Blanleuil ML, Richer JP. The ALPPS technique for bilateral colorectal metastases: three “variations on a theme”. Updat Surg. 2013;65:141–8.

    Article  Google Scholar 

  27. de Santibañes M, Alvarez FA, Santos FR, Ardiles V, de Santibañes E. The associating liver partition and portal vein ligation for staged hepatectomy approach using only segments I and IV as future liver remnant. J Am Coll Surg. 2014;219(2):e5–9.

    Article  PubMed  Google Scholar 

  28. Schadde E, Malagó M, Hernandez-Alejandro R, et al. Monosegment ALPPS hepatectomy: extending resectability by rapid hypertrophy. Surgery. 2015;157(4):676–89.

    Article  PubMed  Google Scholar 

  29. Robles R, Parrilla P, López-Conesa A, Brusadin R, de la Peña J, Fuster M, García-López JA, Hernández E. Tourniquet modification of the associating liver partition and portal ligation for staged hepatectomy procedure. Br J Surg. 2014;101(9):1129–34.

    Article  CAS  PubMed  Google Scholar 

  30. Schadde E, Clavien PA. Reply to letter: “Accelerated liver hypertrophy: ALPPS and more!”. Ann Surg. 2015;261:e46–7.

    Article  PubMed  Google Scholar 

  31. Li J, Kantas A, Ittrich H, Koops A, Achilles EG, Fischer L, Nashan B. Avoid “all-touch” by hybrid ALPPS to achieve oncological efficacy. Ann Surg. 2016;263(1):e6–7.

    Article  PubMed  Google Scholar 

  32. Machado MA, Makdissi FF, Surjan RC. Totally laparoscopic ALPPS is feasible and may be worthwhile. Ann Surg. 2012;256(3):e13.

    Article  PubMed  Google Scholar 

  33. Conrad C, Shivathirthan N, Camerlo A, Strauss C, Gayet B. Laparoscopic portal vein ligation with in situ liver split for failed portal vein embolization. Ann Surg. 2012;256(3):e14–5.

    Article  PubMed  Google Scholar 

  34. Linecker M, Kron P, Lang H, de Santibañes E, Clavien PA. Too many languages in the ALPPS: preventing another tower of babel? Ann Surg. 2016;263(5):837–8.

    Article  PubMed  Google Scholar 

  35. Croome KP, Hernandez-Alejandro R, Parker M, Heimbach J, Rosen C, Nagorney DM. Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis. HPB (Oxford). 2015;17(6):477–84.

    Article  Google Scholar 

  36. Schadde E, Ardiles V, Slankamenac K, et al. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg. 2014;38(6):1510–9.

    Article  PubMed  Google Scholar 

  37. Nadalin S, Testa G, Malagó M, et al. Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl. 2004;10(8):1024–9.

    Article  PubMed  Google Scholar 

  38. Kremer M, Manzini G, Hristov B, Polychronidis G, Mokry T, Sommer CM, Mehrabi A, Weitz J, Büchler MW, Schemmer P. Impact of neoadjuvant chemotherapy on hypertrophy of the future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy. J Am Coll Surg. 2015;221(3):717–28.

    Article  PubMed  Google Scholar 

  39. Tschuor C, Croome KP, Sergeant G, Cano V, Schadde E, Ardiles V, Slankamenac K, Clariá RS, de Santibañes E, Hernandez-Alejandro R, Clavien PA. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion—an extension of the ALPPS approach. Eur J Surg Oncol. 2013;39(11):1230–5.

    Article  PubMed  Google Scholar 

  40. Truant S, Scatton O, Dokmak S, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management. Eur J Surg Oncol. 2015;41(5):674–82.

    Article  CAS  PubMed  Google Scholar 

  41. Schlegel A, Lesurtel M, Melloul E, Limani P, Tschuor C, Graf R, Humar B, Clavien PA. ALPPS: from human to mice highlighting accelerated and novel mechanisms of liver regeneration. Ann Surg. 2014;260(5):839–46.

    Article  PubMed  Google Scholar 

  42. Alvarez FA, Ardiles V, de Santibañes E. The ALPPS approach for the management of colorectal carcinoma liver metastases. Curr Colorectal Cancer Rep. 2013;9(2):168–77.

    Article  Google Scholar 

  43. Tanaka K, Matsuo K, Murakami T, Kawaguchi D, Hiroshima Y, Koda K, Endo I, Ichikawa Y, Taguri M, Tanabe M. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity. Eur J Surg Oncol. 2015;41(4):506–12.

    Article  CAS  PubMed  Google Scholar 

  44. Schadde E, Raptis DA, Schnitzbauer AA, et al. Prediction of mortality after ALPPS stage-1: an analysis of 320 patients from the International ALPPS Registry. Ann Surg. 2015;262:780–5.

    Article  PubMed  Google Scholar 

  45. Matsuo K, Murakami T, Kawaguchi D, Hiroshima Y, Koda K, Yamazaki K, Ishida Y, Tanaka K. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization. Surgery. 2016;159(5):1289–98.

    Article  PubMed  Google Scholar 

  46. de Graaf W, van Lienden KP, Dinant S, et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg. 2010;14(2):369–78.

    Google Scholar 

  47. Serenari M, Collaud C, Alvarez FA, de Santibañes M, Giunta D, Pekolj J, Ardiles V, de Santibañes E. Interstage Assessment of Remnant Liver Function in ALPPS Using Hepatobiliary Scintigraphy: Prediction of Posthepatectomy Liver Failure and Introduction of the HIBA Index. Ann Surg. 2017 Jan 24. doi:10.1097/SLA.0000000000002150. [Epubahead of print].

  48. Schadde E, Schnitzbauer AA, Tschuor C, Raptis DA, Bechstein WO, Clavien PA. Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy. Ann Surg Oncol. 2015;22(9):3109–20.

    Google Scholar 

  49. Torres OJ, Fernandes Ede S, Oliveira CV, Lima CX, Waechter FL, Moraes-Junior JM, Linhares MM, Pinto RD, Herman P, Machado MA. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): the Brazilian experience. Arq Bras Cir Dig. 2013;26(1):40–3.

    Google Scholar 

  50. Ratti F, Schadde E, Masetti M, Massani M, Zanello M, Serenari M, Cipriani F, Bonariol L, Bassi N, Aldrighetti L, Jovine E. Strategies to increase the resectability of patients with colorectal liver metastases: a multi-center case-match analysis of ALPPS and conventional two-stage hepatectomy. Ann Surg Oncol. 2015;22(6):1933–42.

    Google Scholar 

  51. Serenari M, Zanello M, Schadde E, Toschi E, Ratti F, Gringeri E, Masetti M, Cillo U, Aldrighetti L, Jovine E, ALPPS Italian Registry Group. Importance of primary indication and liver function between stages: results of a multicenter Italian audit of ALPPS 2012–2014. HPB (Oxford). 2016;18(5):419–27.

    Google Scholar 

  52. Røsok BI, Björnsson B, Sparrelid E, Hasselgren K, Pomianowska E, Gasslander T, Bjørnbeth BA, Isaksson B, Sandström P. Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure. Surgery. 2016;159(5):1279–86.

    Google Scholar 

  53. Cauchy F, Aussilhou B, Dokmak S, et al. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases. Ann Surg. 2012;256(5):746–54.

    Google Scholar 

  54. Shindoh J, Vauthey JN, Zimmitti G, et al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg. 2013;217(1):126–33.

    Google Scholar 

  55. Tsai S, Marques HP, de Jong MC, et al. Two-stage strategy for patients with extensive bilateral colorectal liver metastases. HPB (Oxford). 2010;12(4):262–9.

    Google Scholar 

  56. Faitot F, Faron M, Adam R, Elias D, Cimino M, Cherqui D, Vibert E, Castaing D, Cunha AS, Goéré D. Two-stage hepatectomy versus 1-stage resection combined with radiofrequency for bilobar colorectal metastases: a case-matched analysis of surgical and oncological outcomes. Ann Surg. 2014;260(5):822–7.

    Google Scholar 

  57. Lam VW, Laurence JM, Johnston E, et al. A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB (Oxford). 2013;15(7):483–91.

    Google Scholar 

  58. Lang SA, Loss M, Benseler V, Glockzin G, Schlitt HJ. Long-term results after in situ split (ISS) liver resection. Langenbeck’s Arch Surg. 2015;400(3):361–9.

    Google Scholar 

  59. Clavien PA, Lillemoe KD. Note from the editors on the ALPPS e-Letters-to-the-Editor. Ann Surg. 2012;256(3):552.

    Google Scholar 

  60. de Santibañes E, Alvarez FA, Ardiles V, et al. Inverting the ALPPS paradigm by minimizing first stage impact: the Mini-ALPPS technique. Langenbeck’s Arch Surg. 2016;401:557–63.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. General Surgery Service and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Juan D. Perón 4190, C1181ACH, Buenos Aires, Argentina

    Fernando A. Alvarez MD & Eduardo de Santibañes MD, PhD

Authors
  1. Fernando A. Alvarez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eduardo de Santibañes MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eduardo de Santibañes MD, PhD .

Editor information

Editors and Affiliations

  1. General Surgery Department HPB and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    Eduardo de Santibañes

  2. General Surgery Department HPB and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    Victoria Ardiles

  3. General Surgery Department HPB and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    Fernando A. Alvarez

  4. General Surgery Department HPB and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    Virginia Cano Busnelli

  5. General Surgery Department HPB and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    Martin de Santibañes

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Alvarez, F.A., de Santibañes, E. (2017). Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS). In: de Santibañes, E., Ardiles, V., Alvarez, F., Busnelli, V., de Santibañes, M. (eds) Extreme Hepatic Surgery and Other Strategies. Springer, Cham. https://doi.org/10.1007/978-3-319-13896-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-13896-1_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-13895-4

  • Online ISBN: 978-3-319-13896-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation